TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Life Insurance Corporation of India
LICILarge CapNSEBSE
Financials · Financial Services
₹416.30up 2.35up 0.57 percentas of 28 Aug 2026
Book value ₹140.17Div yield 2.40%
Key metrics
- Market Cap
- 5,31,595.01 ₹ cr
- P/E
- 9.11 x
- P/B
- 2.97 x
- ROE
- 8.85%
- ROCE
- 1.71%
- Debt to Equity
- 6.98 x
- Net Margin
- 18.69%
- Dividend Yield
- 2.40%
- Revenue Growth (YoY)
- 6.98%
Observations
Mechanical observations generated from stored data, not analysis or opinion. Each one names the threshold that produced it — the ROCE check below uses 20%, a fixed default rather than a value tailored to this company.
- Revenue grew year-on-year in each of the last 3 years.
- Net margin grew year-on-year in each of the last 3 years.
- Promoter holding 96.5% (pledge data not available).
- Debt-to-equity 6.98 — above the Financial Services median of 5.53.
LICI
₹416.30up 0.57 percent
EOD Synced: 28 Aug 2026 18:30 ISTOverview & Live Price Chart
Executive Investment Verdict & Quality Synthesis
Autonomous V2Multi-dimensional quantitative synthesis across capital efficiency, forensic accounting, intrinsic valuation, and ownership governance.
Factual Quantitative Consensus
1. Capital Efficiency & MoatModerate Return
—ROCE
ROE: 32.53%·P/B: 2.97x
2. Forensic Health & SolvencyCAMEL Regulated Resilient
CAMEL PassBanking Matrix
CRAR & NPA Reserves Aligned
3. Valuation & DCF Spread+574.8% Margin of Safety
₹2,809DCF Fair Value
CMP: ₹416.3
4. Ownership & GovernanceClean Promoter Holding
96.50%Promoter Stake
Pledged: 0.0%·Inst: 1.28%
Institutional Factor Scores
QVGM Factor Grade Matrix
Institutional Multi-Factor Profile (QVGM)
Composite 0–100 percentile ranks normalized across all 500 universe constituents
Rank #73 of 86 in FinancialsQVGM 47/100
Quality (Q)23
ROE, ROCE, Margins & Cash Conversion
Value (V)79
P/E, P/B, EV/EBITDA vs Sector Benchmarks
Growth (G)44
3Y Sales & EPS Compounded Growth
Momentum (M)47
Relative Strength & Trend Position
TheScreener Radar™ 5-Pillar Quantitative Scorecard
Holistic quantitative radar evaluating fundamental quality, valuation multiples, balance sheet health, growth, and price momentum
Sector Rank:Rank #73 of 86 in Financials
Valuation
Strong79/100
P/E Ratio:9.11x
P/B Ratio:2.97x
Dividend Yield:2.40%
P/E, P/B, EV/EBITDA & Dividend Yield relative to 5Y medians and sector
Growth
Moderate44/100
3Y Sales CAGR:—
3Y PAT CAGR:—
Quarterly YoY:+12.4%
3-Year Compounded Sales & Net Profit Growth trajectory
Profitability
Weak23/100
ROE:32.5%
ROCE:—
OPM %:—
Return on Equity (ROE), ROCE & Operating Margin efficiency
Solvency & Health
Strong78/100
Piotroski F-Score:7/9
Altman Z-Score:—
Debt / Equity:0.00
Balance Sheet strength, Altman Z-Score & Piotroski F-Score checklist
Momentum
Moderate47/100
1Y Return:—
RSI (14):54.2
From 52W High:—
1-Year Relative Strength vs NIFTY 500, RSI-14 & 52W High distance
Quantitative Drivers & Growth Analysis
52-week corridor, deep valuation multiples, compounded CAGR trajectory, and institutional flow shifts
52-Week Low₹362.83
From 52W High-9.91%
52-Week High₹462.08
Valuation MultiplesCash Flow & Yield
PEG Ratio0.65
Earnings Yield28.71%
Price / FCF—
FCF Yield-0.04%
Payout Ratio8.37%
Net-Net Ratio-3.66
Solvency & SafetyPiotroski & Altman
Piotroski F-Score7/9
Altman Z-Score—
Graham Number₹614.00
1Y Flow & Margin ShiftsTrailing 12M
FII Stake:▲ +0.11%
DII Stake:▼ 0.10%
OPM Margin:▲ +0.14%
Net Margin:▲ +0.48%
Compounded Annual Growth Rate (CAGR Matrix)
Historical Fundamental Trajectory| Metric | QoQ Shift | YoY Shift | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Revenue Growth | ▼ 13.84% | ▲ +6.98% | 9.19% | 7.34% | 7.24% |
| Net Profit Growth | ▼ 42.11% | ▲ +23.98% | 18.90% | 16.86% | 80.80% |
| EPS Growth | ▼ 70.30% | ▲ +28.32% | 16.56% | 14.09% | 79.66% |
Intrinsic Valuation Models & DCF Sensitivity
Institutional DCF & Intrinsic Valuation Studio — LICI
2-Stage Discounted Cash Flow, Reverse DCF Implied Growth, and Benjamin Graham & Peter Lynch valuation benchmarks.
DCF Intrinsic Fair Value
₹3,116.9
Verdict:Undervalued (+648.7%)
Benjamin Graham Number
₹371.7
-10.7% vs CMPPeter Lynch Fair Value
₹220.0
-47.2% vs CMPReverse DCF Implied Growth
-20.0% CAGR
Modest Expectations (High Margin of Safety)Valuation Spectrum PositioningCMP: ₹416.3
₹0 (Distress)CMP: ₹416DCF: ₹3,117Graham: ₹372
Scenario Calibration & Sensitivity Levers
Tune Discount Rate (WACC), 5-Year Growth, and Terminal Value to model bear, base, and bull cases.
Discount Rate (WACC)11.5%
Cost of Capital Hurdle
5-Year FCF Growth CAGR30.0%
Assumed stage-1 cash flow expansionTerminal Growth Rate4.5%
Long-term perpetual GDP growth rate5-Year Projected Cash Flow Schedule (₹ Cr)
| Projection Period | Growth Rate | Projected FCF | Discount Factor | Present Value |
|---|---|---|---|---|
| Year 1 | 30% | ₹1,26,506 | 0.8969 | ₹1,13,458 |
| Year 2 | 30% | ₹1,64,457 | 0.8044 | ₹1,32,283 |
| Year 3 | 30% | ₹2,13,795 | 0.7214 | ₹1,54,231 |
| Year 4 | 30% | ₹2,77,933 | 0.6470 | ₹1,79,821 |
| Year 5 | 30% | ₹3,61,313 | 0.5803 | ₹2,09,657 |
2D Sensitivity Matrix (WACC vs Terminal Growth Rate)
Click any cell to apply WACC & terminal growth scenario. Values in ₹ / share.| WACC \ g(Terminal) | 3.0% | 4.0% | 4.5% | 5.0% | 6.0% |
|---|---|---|---|---|---|
| 10.0% | ₹3281 +688% | ₹3745 +800% | ₹4041 +871% | ₹4396 +956% | ₹5371 +1190% |
| 11.0% | ₹2834 +581% | ₹3170 +662% | ₹3377 +711% | ₹3618 +769% | ₹4245 +920% |
| 11.5% | ₹2651 +537% | ₹2941 +606% | ₹3117 +649% | ₹3320 +697% | ₹3837 +822% |
| 12.0% | ₹2488 +498% | ₹2740 +558% | ₹2892 +595% | ₹3065 +636% | ₹3497 +740% |
| 13.0% | ₹2213 +431% | ₹2407 +478% | ₹2522 +506% | ₹2651 +537% | ₹2963 +612% |
Discounted cash flow (DCF) and valuation models are quantitative projections based on user-supplied assumptions — not a forecast, not a guarantee of future performance, and not SEBI-registered investment advice. Actual financial performance and stock price movements may differ materially.
New to intrinsic valuation models? Learn how Discounted Cash Flow and Terminal Growth rates work.Read DCF Academy Guide →
Valuation history
P/E9.11current
ReportedComputed, approximate
P/B2.97current
ReportedComputed, approximate
The dashed line is computed from historical close price divided by the most recently reported annual EPS or book value — not IndianAPI's own figure, which only ever gives a single current reading with no history behind it. Real results are typically disclosed several weeks after the fiscal year ends, so a computed point right around a year transition can lag what the market actually knew that day. The solid line is the real reported figure.
EV/EBITDA is not shown — there is no verified source for it in our data feed, and estimating it would misrepresent an estimate as a reported figure.
| Date | P/E | P/B |
|---|---|---|
| 31 Aug 2026 | 9.11 | 2.97 |
Analyst Consensus, Price Targets & Forecasts
Analyst Consensus & Recommendations
Aggregated institutional equity research ratings · 31 Aug 2026
Strong Buy(1.79 / 5)
Strong Buy:9
Buy:6
Hold:3
Sell:1
Strong Sell:0
Coverage: 19 contributing analystsScale: 1 (Strong Buy) – 5 (Strong Sell)
Ratings shown are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Risk Profile & Volatility
Statistical return volatility classification · 31 Aug 2026
Balanced risk
Low RiskModerate RiskHigh Risk
Annualised Standard Deviation:29.42%
Analyst Price Targets
12-month forward price consensus · 31 Aug 2026
Upside: +166.15%
Mean Target₹1,108.00vs CMP ₹416.30
High Target₹1,450.00+248.3% max upside
Low Target₹850.00104.2% downside
Median Target₹1,100.0019 estimates
Low: ₹850.00Mean: ₹1,108.00High: ₹1,450.00
Mean Target Current Price (₹416.30)
Price targets are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Forward Financial Forecasts & Consensus Estimates
Institutional broker consensus estimates and forward earnings trajectory
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
₹0.95
Low:—
High:—
FY2024EConsensus
Mean Estimate
₹12.70
Low:—
High:—
FY2024E1 Analysts
Mean Estimate
₹14.97
Low:—
High:—
FY2024E1 Analysts
Mean Estimate
₹21.79
Low:—
High:—
FY2024EConsensus
Mean Estimate
₹15.23
Low:—
High:—
FY2025E1 Analysts
Mean Estimate
₹12.22
Low:—
High:—
FY2025E1 Analysts
Mean Estimate
₹17.40
Low:—
High:—
FY2025E1 Analysts
Mean Estimate
₹30.10
Low:—
High:—
FY2025E1 Analysts
Mean Estimate
₹16.67
Low:—
High:—
FY2026E1 Analysts
Mean Estimate
₹15.97
Low:—
High:—
FY2026E1 Analysts
Mean Estimate
₹17.26
Low:₹17.00
High:₹17.00
FY2026E1 Analysts
Mean Estimate
₹24.64
Low:₹24.00
High:₹24.00
FY2026E1 Analysts
Mean Estimate
₹17.32
Low:—
High:—
| Period / Fiscal Year | Consensus Mean | Bull Case (High) | Bear Case (Low) | Brokers |
|---|---|---|---|---|
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | ₹0.95 | — | — | — |
| FY2024 Forecast | ₹12.70 | — | — | — |
| FY2024 Forecast | ₹14.97 | — | — | 1 |
| FY2024 Forecast | ₹21.79 | — | — | 1 |
| FY2024 Forecast | ₹15.23 | — | — | — |
| FY2025 Forecast | ₹12.22 | — | — | 1 |
| FY2025 Forecast | ₹17.40 | — | — | 1 |
| FY2025 Forecast | ₹30.10 | — | — | 1 |
| FY2025 Forecast | ₹16.67 | — | — | 1 |
| FY2026 Forecast | ₹15.97 | — | — | 1 |
| FY2026 Forecast | ₹17.26 | ₹17.00 | ₹17.00 | 1 |
| FY2026 Forecast | ₹24.64 | ₹24.00 | ₹24.00 | 1 |
| FY2026 Forecast | ₹17.32 | — | — | 1 |
Third-party broker forecasts compiled from institutional research houses, not IndiScreener's proprietary estimates. Provided strictly for analytical benchmarking and does not constitute investment advice.
Forensic Accounting Audit & Solvency Risk
Accounting Health & Governance Quality Radar
Algorithmic accounting analysis across balance sheet solvency, cash conversion efficiency, and ownership stability.
Governance Watchouts Flagged
Financial Strengths & Catalysts
3 Factors- •Company has delivered a high Return on Equity (ROE) of 32.5%.
- •Company is virtually debt-free with a Debt-to-Equity ratio of 0.00x.
- •High promoter holding of 96.5% with zero encumbrance / pledge.
Risk Factors & Watchouts
2 Watchouts- •Cash conversion lag: Operating Cash Flow is below 50% of reported Net Profit.
- •Persistent negative operating cash flow despite reported positive accounting profits.
Forensic Accounting & Health Audit
CAMEL Banking Model & Quality Factor Composite
Piotroski F-Score7 / 9
● Strong (High Quality)
Altman Z-Score—
● Not Applicable for Banks/NBFCs
Beneish M-Score-2.46
● Low Risk (Clean Accounting)
Cash flows closely match reported earnings with conservative accruals.
CAMEL Banking & NBFC Resilience ScorecardNet Profit: ₹57,453.15 Cr
Capital Adequacy (CRAR)14.0%Adequate (>= 15.0%)
Asset Quality (Gross NPA)0.8%Clean (< 2.5%)
Provision Coverage (PCR)88.0%Well-Provisioned (>= 70.0%)
Net Interest Margin (NIM)2.5%Moderate (>= 3.2%)
Cost-to-Income Ratio65.0%Elevated (< 50.0%)
Learn how Piotroski F-Score (9 criteria) and Altman Z-Score detect earnings manipulation and bankruptcy risk.Read Forensic Guide →
10-Year Financial Statements & DuPont ROE
Financial Statements
consolidated · amounts in ₹ Crores
Accounting Flow:
Wall Street Cash Flow & Free Cash Flow (FCF) Cascade
FY26 (2025-2026)3-Stage institutional flow from reported earnings to owner Free Cash Flow and capital allocation
FCF Conversion Rate (FCF / PAT)
-47.6%Low Cash Conversion
Measures how much reported accounting profit turns into real liquid cash.
Free Cash Flow Margin
-2.8%of Gross Revenue
Liquid cash retained per ₹100 of top-line revenue generated.
CapEx Reinvestment Rate
—of Operating Cash
Portion of operating cash reinvested in future capacity and maintenance.
Reported Net Profit (PAT)₹57,453 CrInflow
57,453
+ D&A Non-Cash Charge₹707 CrAdd-back
707
Working Capital Adjustment-₹84,371 Cr- Tied Up
84,371
= Operating Cash Flow (CFO)-₹26,211 CrOperating Cash
26,211
- Capital Expenditures (CapEx)-₹1,116 CrReinvestment
1,116
= Free Cash Flow (FCF)-₹27,327 CrFree Cash Flow
27,327
- Dividends & Debt Repayment-₹12,640 CrCapital Return
12,640
= Net Change in Cash-₹39,967 CrNet Balance
39,967
Multi-Year Historical FCF vs Reported PAT Trajectory:
Free Cash Flow (FCF) Reported Net Profit (PAT)
| Metric | 2018-201931 Mar 2019 | 2019-202031 Mar 2020 | 2020-202131 Mar 2021 | 2021-202231 Mar 2022 | 2022-202331 Mar 2023 | 2023-202431 Mar 2024 | 2024-202531 Mar 2025 | 2025-202631 Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5.65 L | ₹6.26 L | ₹6.86 L | ₹7.24 L | ₹7.87 L | ₹8.42 L | ₹8.91 L | ₹9.73 L |
| Operating profit | ₹-2,292.21 | ₹-9,224.19 | ₹-364.47 | ₹-961.52 | ₹24,097.75 | ₹22,156.46 | ₹40,049.38 | ₹45,121.32 |
| OPM | -0.41% | -1.47% | -0.05% | -0.13% | 3.06% | 2.63% | 4.49% | 4.64% |
| Net profit | ₹2,627.38 | ₹2,710.48 | ₹2,974.14 | ₹4,124.71 | ₹35,996.65 | ₹40,915.85 | ₹48,320.33 | ₹57,453.15 |
| EPS | 2.08 | 2.14 | 2.35 | 2.64 | 29.62 | 28.67 | 37.74 | 43.99 |
| Net margin | 0.47% | 0.43% | 0.43% | 0.57% | 4.57% | 4.86% | 5.42% | 5.90% |
| ROE | 324.50% | 270.55% | 43.20% | 36.38% | 77.86% | 49.45% | 37.98% | 32.53% |
| ROCE | — | — | — | — | — | — | — | — |
| Debt / equity | 332.73 | 252.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Compounded growth (CAGR)
| Metric | 1Y | 3Y | 5Y |
|---|---|---|---|
| Revenue | 9.19% | 7.34% | 7.24% |
| Net profit | 18.90% | 16.86% | 80.80% |
| EPS | 16.56% | 14.09% | 79.66% |
Each column only appears when 8 real reported years actually support it — never extrapolated from fewer.
Balance sheet
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₹34.27 L | ₹35.00 L | ₹38.30 L | ₹42.54 L | ₹45.78 L | ₹53.16 L | ₹56.61 L | ₹59.49 L |
| Total liabilities | ₹34.26 L | ₹34.99 L | ₹38.23 L | ₹42.43 L | ₹45.32 L | ₹52.33 L | ₹55.33 L | ₹57.72 L |
| Total equity | ₹809.67 | ₹1,001.83 | ₹6,883.97 | ₹11,337.17 | ₹46,232.87 | ₹82,746.87 | ₹1.27 L | ₹1.77 L |
| Total debt | ₹2.69 L | ₹2.53 L | ₹3.67 | ₹1.29 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| Cash | ₹32,886.63 | ₹31,990.01 | ₹21,312.52 | ₹24,655.32 | ₹23,107.99 | ₹25,340.84 | ₹40,066.15 | ₹23,540.62 |
| Current assets | — | — | — | — | — | — | — | — |
| Current liabilities | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Receivables | — | — | — | — | — | — | — | — |
| Payables | — | — | — | — | — | — | — | — |
| Net PP&E | ₹14,567.58 | ₹14,571.78 | ₹3,474.03 | ₹3,549.48 | ₹3,821.34 | ₹4,063.65 | ₹4,474.25 | ₹4,727.27 |
| Retained earnings | ₹713.23 | ₹758.55 | ₹6,586.94 | ₹4,746.96 | ₹39,788.49 | ₹76,278.44 | ₹1.21 L | ₹1.71 L |
Cash flow
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | ₹13,273.81 | ₹54,366.92 | ₹80,602.04 | ₹-3,782.54 | ₹54,518.51 | ₹26,121.65 | ₹-9,144.77 | ₹-26,211.48 |
| Capital expenditure | ₹-2,545.80 | ₹-1,120.26 | ₹-1,076.07 | ₹-716.94 | ₹-886.47 | ₹-767.77 | ₹-776.73 | ₹-1,115.78 |
| Free cash flow | ₹10,728.01 | ₹53,246.66 | ₹79,525.97 | ₹-4,499.48 | ₹53,632.04 | ₹25,353.88 | ₹-9,921.50 | ₹-27,327.26 |
| OCF / net profit | 5.05 | 20.06 | 27.10 | -0.92 | 1.51 | 0.64 | -0.19 | -0.46 |
| FCF / Capex intensity | 0.45 | 0.18 | 0.16 | 0.10 | 0.11 | 0.09 | 0.09 | 0.11 |
Income statement detail
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| EBITDA | ₹-1,863.63 | ₹-8,445.68 | ₹354.31 | ₹-525.33 | ₹24,564.13 | ₹22,622.40 | ₹40,555.85 | ₹45,828.02 |
| Income before tax | ₹-542.24 | ₹-4,228.60 | ₹2,263.52 | ₹-31.81 | ₹31,897.26 | ₹36,985.12 | ₹43,544.52 | ₹50,542.80 |
| Interest expense | — | — | — | — | — | — | — | — |
| Tax expense | ₹14.99 | ₹8.04 | ₹6.21 | ₹39.87 | ₹84.29 | ₹140.75 | ₹30.28 | ₹70.73 |
| D&A | ₹428.58 | ₹778.51 | ₹718.78 | ₹436.19 | ₹466.38 | ₹465.94 | ₹506.47 | ₹706.70 |
| EBITDA margin | -0.33% | -1.35% | 0.05% | -0.07% | 3.12% | 2.69% | 4.55% | 4.71% |
Financial ratios
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | — | — | — | — | — | — | — | — |
| Quick ratio | — | — | — | — | — | — | — | — |
| Interest coverage | — | — | — | — | — | — | — | — |
| Inventory days | — | — | — | — | — | — | — | — |
| Receivable days | — | — | — | — | — | — | — | — |
| Payable days | — | — | — | — | — | — | — | — |
| Cash conversion cycle | — | — | — | — | — | — | — | — |
| Working capital days | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
| Fixed asset turnover | 38.75 | 42.96 | 197.49 | 203.98 | 205.91 | 207.20 | 199.18 | 205.85 |
| ROA | 0.08% | 0.08% | 0.08% | 0.10% | 0.79% | 0.77% | 0.85% | 0.97% |
| ROIC | -0.99% | -4.16% | 2.52% | 16.27% | 103.93% | 38.45% | 45.92% | 29.44% |
| Gross margin | — | — | — | — | — | — | — | — |
DuPont 3-Stage ROE Factor Decomposition
Deconstructing Return on Equity into Profitability, Asset Efficiency, and Financial Leverage
Leverage Driven (Elevated Debt Contribution)FY2025-2026
Net marginProfitability
5.90%
Net Profit generated per ₹100 of revenue (Profitability)
×
Asset turnoverEfficiency
0.16
Revenue generated per ₹1 of total assets (Capital Efficiency)
×
Equity multiplierLeverage
33.68
Total assets supported per ₹1 of shareholder equity (Leverage)
=
Implied DuPont ROEFinal Output
32.53%
Reported: 32.53%
Explore the 3-Stage DuPont Formula: Net Margin × Asset Turnover × Leverage Multiplier.Read DuPont Guide →
Corporate Actions, Dividends & Capital Changes
Chronological Corporate Actions Registry
Historical stock splits, bonus shares, rights issues, and corporate schemes
| Year | Execution Date | Action Type | Ratio / Term |
|---|---|---|---|
| 2026 | 25 Jun 2026 | dividend | 100% |
| 29 May 2026 | bonus | 1:1 | |
| 2025 | 25 Jul 2025 | dividend | 120% |
| 2024 | 19 Jul 2024 | dividend | 60% |
| 21 Feb 2024 | dividend | 40% | |
| 2023 | 21 Jul 2023 | dividend | 30% |
| 2022 | 26 Aug 2022 | dividend | 15% |
Dividend Intelligence & Capital Return History
Historical cash payout track record across 6 dividend distributions
Latest Year DPS:₹10.00
Yield on CMP:2.40%
3Y Dividend CAGR:+49.4%
Annual Dividend Payout Progression (Per Share)Total Cumulative DPS: ₹36.50
₹10.0
2026
₹12.0
2025
₹10.0
2024
₹3.0
2023
₹1.5
2022
| Ex-Date | Amount (Per Share) | Dividend Type |
|---|---|---|
| 25 Jun 2026 | ₹10.00 | Final |
| 25 Jul 2025 | ₹12.00 | Final |
| 19 Jul 2024 | ₹6.00 | Final |
| 21 Feb 2024 | ₹4.00 | Interim |
| 21 Jul 2023 | ₹3.00 | Final |
| 25 Aug 2022 | ₹1.50 | Final |
Industry Peer Group & Valuation Spread
Compare valuation multiples and market cap relative to sector competitors
Financial ServicesCompare Peers in Studio
Market Cap5,31,595.01 ₹ cr
Beats 97% of 117 industry peers · median 35,401.63 ₹ cr
P/E9.11 x
Beats 12% of 99 industry peers · median 22.17 x
P/B2.97 x
Beats 60% of 99 industry peers · median 2.53 x
ROE8.85%
Beats 19% of 118 industry peers · median 17.33%
ROCE1.71%
Beats 6% of 93 industry peers · median 5.18%
Debt to Equity6.98 x
Beats 87% of 118 industry peers · median 5.53 x
Net Margin18.69%
Beats 44% of 112 industry peers · median 19.19%
Dividend Yield2.40%
Beats 76% of 89 industry peers · median 0.92%
Revenue Growth (YoY)6.98%
Beats 22% of 85 industry peers · median 19.34%
| Company | Market Cap ▼ | P/E | P/B |
|---|---|---|---|
HDFC Bank Ltd.HDFCBANK | ₹11.10 L | 14.43 | 1.87 |
ICICI Bank Ltd.ICICIBANK | ₹10.23 L | 19.29 | 2.85 |
| ₹9.66 L | 11.44 | 1.61 | |
Bajaj Finance Ltd.BAJFINANCE | ₹6.63 L | 35.40 | 5.89 |
Kotak Mahindra Bank Ltd.KOTAKBANK | ₹4.22 L | 21.87 | 2.33 |
Peers are chosen strictly by industry classification. A classification doesn't always describe what a company actually competes in, but gives an objective starting point across the universe.
Regulatory Filings & Market Intelligence
Corporate Filings & Document Vault
SEBI LODR VerifiedAudited Annual Reports, Investor Decks, Earnings Concall Transcripts, and Board Resolutions for Life Insurance Corporation of India (LICI)
Indexed Documents6 Filings
Latest Disclosure22 Jul 2026
Board Outcome22 Jul 2026
Life Insurance Corporation of India: Outcome of Board Meeting for Approval of Audited Financial Results
Secretarial Filing09 Jul 2026
Life Insurance Corporation of India: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Shareholding16 May 2026
Life Insurance Corporation of India: Quarterly Statement of Shareholding Pattern filed with NSE/BSE
AGM / EGM04 May 2026
Life Insurance Corporation of India: Notice of Annual General Meeting and Record Date for Dividend
Press Release27 Apr 2026
Life Insurance Corporation of India: Press Release: Business Updates and New Strategic Initiatives
News
- IndianAPIMcap of four of top-10 most valued firms erodes ₹87,960 crore; Airtel takes biggest hit
The combined market valuation of four of the top 10 most valued firms in India eroded by ₹87,960.29 crore last week, with Bharti Airtel taking the biggest hit, in-tandem with a bearish trend in equities.
- IndianAPIGoldman Sachs names Chandresh Chheda as co-head of India investment banking
Goldman Sachs has appointed former JPMorgan executive Chandresh Chheda as managing director and co-head of India investment banking. His appointment comes as India’s IPO, ECM and M&A markets remain strong, with Goldman expanding its dealmaking franchise.
- IndianAPICentre rakes in nearly 74% of ₹80,000-cr FY27 asset-sale target in four months
The government has raised ₹51,787 crore so far this financial year through stake sales in public sector companies, according to official data reviewed by Mint, with a bulk of the proceeds coming from the share sale in Life Insurance Corporation of India Ltd (LIC).
- IndianAPIQ1 results 2026: LIC to Trent among companies to declare Q1 results today; full list here
Life Insurance Corporation of India (LIC), Trent, Hero Motocorp, Lupin, Emcure Pharmaceuticals, Britannia Industries, Fortis Healthcare are among the companies to report their Q1 results FY27 today.
- IndianAPILIC sets board meeting date to declare Q1 results 2026. Check details
Life Insurance Corporation of India (LIC) will hold a Board meeting on August 6, 2026, to approve financial results for the quarter ending June 30, 2026. Investors await updates on premium growth and profitability. The trading window will remain closed until August 8, 2026.
- IndianAPICan cooperative insurance become India’s next financial inclusion story?
The proposed national cooperative life insurer is about more than adding another player—it could shift India's insurance journey from expanding access to building financial resilience.
- IndianAPIMcap of 4 of top-10 most valued firms jumps ₹92,995 cr; HDFC Bank, Airtel top gainers
The gainers from the top-10 pack were RIL, HDFC Bank, Bharti Airtel and LIC, while ICICI Bank, SBI, TCS, Bajaj Finance, L&T and Hindustan Unilever faced a combined erosion of ₹49,294.13 crore from their valuation
- IndianAPIMcap of 6 of top-10 most valued firms surges by ₹1 lakh crore; Airtel, Bajaj Finance top gainers
Stock market today: During the week, the BSE Sensex advanced 663.44 points, or 0.86%, while the NSE Nifty climbed 214.85 points, or 0.89%.
- IndianAPIIRDAI plans insurance commission overhaul to curb mis‑selling with staggered payouts and stricter transparency rules
IRDAI plans to implement staggered commissions, spreading payouts over the policy term to improve transparency, reduce churn and align distributor incentives with customer needs across India’s insurance market.
- IndianAPIStock market today: Gift Nifty hints flat start; US-Iran talks, weak yen to crude oil prices - 8 stocks to buy or sell
The Indian stock market may open quietly on Wednesday, influenced by global market trends. Domestic indices dropped yesterday, with the Nifty 50 and BSE Sensex both closing lower. Oil prices rose slightly amid ongoing geopolitical tensions between the US and Iran.
- IndianAPIMcap of 6 of top-10 most valued firms surges by ₹88,678 crore; ICICI Bank biggest gainer
During the week, the BSE Sensex advanced 297.57 points, or 0.38%, while the NSE Nifty rose 42.9 points, or 0.17%.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.